Independent research on the U.S. markets, Baptista Research

Baptista Research

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. 

We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Albertsons Companies recently reported its fourth quarter and fiscal year-end 2024 results, revealing mixed financial metrics and future prospects.</li><li>The company achieved an identical (ID) sales growth of 2.3%, primarily driven by a significant 18% increase in pharmacy sales and a robust 24% rise in digital sales.</li><li>Despite the top-line growth, gross margins, excluding fuel and LIFO expense, decreased by 45 basis points due to increased healthcare sales and delivery costs, offset partly by productivity gains.</li></ul>

Albertsons Companies recently reported its fourth quarter and fiscal year-end 2024 results, revealing mixed financial metrics and future prospects.The company achieved an identical (ID) sales growth of 2.3%, primarily driven by a significant 18% increase in pharmacy sales and a robust 24% rise in digital sales.Despite the top-line growth, gross margins, excluding fuel and LIFO expense, decreased by 45 basis points due to increased healthcare sales and delivery costs, offset partly by productivity gains.

앨버트슨은 스마트한 가격 책정과 최첨단 기술로 수익을 확대하고 큰 성공을 거두고 있습니다!

Albertsons Cos

앨버트슨은 스마트한 가격 책정과 최첨단 기술로 수익을 확대하고 큰 성공을 거두고 있습니다!